4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
vTv Therapeutics Inc. (VTVT) operates in the Biotechnology industry and is headquartered in High Point, United States with about 26 employees. Its market capitalization is roughly $132 million. In the fiscal year ended 2025-12-31, VTVT reported $0M in revenue and ($27M) in net income.
vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases.
Interactive charts & full statements → Open the VTVT valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $1M | $0M | $2M |
| Operating Income (EBIT) | ($33M) | ($24M) | ($26M) | ($22M) |
| Net Income | ($27M) | ($18M) | ($20M) | ($19M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $37M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | $23M | ($8M) | ($11M) | ($8M) | ($6M) | — |
| Net Income | $24M | ($7M) | ($9M) | ($6M) | ($5M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $90M | $38M | $11M | $33M | — |
| Total Liabilities | $26M | $24M | $30M | $27M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VTVT viewer.
About TickerBase · Data methodology & sources